355 times volume spurt: Pharma stock jumps 17.5% post Q1FY26 results; FIIs increase stake & DIIs took a fresh entry!

On Thursday, shares of Lincoln Pharmaceuticals Ltd jumped 17.5 per cent to an intraday high of Rs 624.80 per share from its previous closing of Rs 531.85 per share. The stock’s 52-week high is Rs 975 per share and its 52-week low is Rs 500 per share. The shares of the company saw a spurt in volume by more than 355 times on the BSE.

Lincoln Pharmaceuticals Ltd, established in 1979, manufactures and trades pharmaceutical products. The company offers over 600 formulations across 15 therapeutic areas, with 1700 registered products and 700 more in development. They hold 7 patents and have applied for over 25 additional ones, covering a wide range of therapeutic needs from dermatology and gynaecology to anti-infectives and cardiac medications.

According to Quarterly Results, the net sales increased by 5 per cent to Rs 154 crore and net profit increased by 17 per cent to Rs 28 crore in Q1FY26 compared to Q1FY25. In FY25, the company reported net sales of Rs 623 crore and net profit of Rs 82 crore.

The company has a market cap of over Rs 1,220 crore with a PE of 14x whereas the industry PE is 32x. The stock has an ROE of 13 per cent and an ROCE of 18 per share. In June 2025, FIIs bought 28,654 shares and increased their stake to 5.13 per cent compared to March 2025 while DIIs took a fresh entry and bought 2,178 shares or 0.01 per cent stake in the company. The stock is up by 25 per cent from its 52-week low of Rs 500 per share.

Disclaimer: The article is for informational purposes only and not investment advice.